Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

The effect of anesthetic management during intra-arterial therapy for acute stroke in MR CLEAN.

Berkhemer OA, van den Berg LA, Fransen PS, Beumer D, Yoo AJ, Lingsma HF, Schonewille WJ, van den Berg R, Wermer MJ, Boiten J, Lycklama À Nijeholt GJ, Nederkoorn PJ, Hollmann MW, van Zwam WH, van der Lugt A, van Oostenbrugge RJ, Majoie CB, Dippel DW, Roos YB; MR CLEAN investigators.

Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000002976. [Epub ahead of print]

PMID:
27421546
2.

Preventive Ceftriaxone in Patients with Stroke Treated with Intravenous Thrombolysis: Post Hoc Analysis of the Preventive Antibiotics in Stroke Study.

Vermeij JD, Westendorp WF, Roos YB, Brouwer MC, van de Beek D, Nederkoorn PJ; PASS Investigators.

Cerebrovasc Dis. 2016 Jun 24;42(5-6):361-369. [Epub ahead of print]

PMID:
27336314
3.

Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.

Baharoglu MI, Cordonnier C, Al-Shahi Salman R, de Gans K, Koopman MM, Brand A, Majoie CB, Beenen LF, Marquering HA, Vermeulen M, Nederkoorn PJ, de Haan RJ, Roos YB; PATCH Investigators.

Lancet. 2016 Jun 25;387(10038):2605-13. doi: 10.1016/S0140-6736(16)30392-0. Epub 2016 May 10.

PMID:
27178479
4.

Statins and poststroke intracerebral hemorrhage: Concern but increasing reassurance.

Goldstein LB, Nederkoorn PJ.

Neurology. 2016 Apr 26;86(17):1570-1. doi: 10.1212/WNL.0000000000002618. Epub 2016 Mar 25. No abstract available.

PMID:
27016517
5.

Association between i.v. thrombolysis volume and door-to-needle times in acute ischemic stroke.

Groot AE, van Schaik IN, Visser MC, Nederkoorn PJ, Limburg M, Aramideh M, de Beer F, Zwetsloot CP, Halkes P, de Kruijk J, Kruyt ND, van der Meulen W, Spaander F, van der Ree T, Kwa VI, Van den Berg-Vos RM, Roos YB, Coutinho JM.

J Neurol. 2016 Apr;263(4):807-13. doi: 10.1007/s00415-016-8076-5. Epub 2016 Mar 5.

6.

Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.

Van Montfrans JM, Hartman EA, Braun KP, Hennekam EA, Hak EA, Nederkoorn PJ, Westendorp WF, Bredius RG, Kollen WJ, Schölvinck EH, Legger GE, Meyts I, Liston A, Lichtenbelt KD, Giltay JC, Van Haaften G, De Vries Simons GM, Leavis H, Sanders CJ, Bierings MB, Nierkens S, Van Gijn ME.

Rheumatology (Oxford). 2016 May;55(5):902-10. doi: 10.1093/rheumatology/kev439. Epub 2016 Feb 10.

7.

Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke.

Gensicke H, Strbian D, Zinkstok SM, Scheitz JF, Bill O, Hametner C, Moulin S, Zini A, Kägi G, Pezzini A, Padjen V, Béjot Y, Corbiere S, Zonneveld TP, Seiffge DJ, Roos YB, Traenka C, Putaala J, Peters N, Bonati LH, Curtze S, Erdur H, Sibolt G, Koch P, Vandelli L, Ringleb P, Leys D, Cordonnier C, Michel P, Nolte CH, Lyrer PA, Tatlisumak T, Nederkoorn PJ, Engelter ST; Thrombolysis in Stroke Patients (TriSP) Collaborators.

Stroke. 2016 Feb;47(2):450-6. doi: 10.1161/STROKEAHA.115.011674.

PMID:
26797662
8.

Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical Trial.

Fransen PS, Berkhemer OA, Lingsma HF, Beumer D, van den Berg LA, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Lycklama À Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog HM, Gerrits DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van Oostenbrugge RJ, Majoie CB, van der Lugt A, Dippel DW; Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands Investigators.

JAMA Neurol. 2016 Feb;73(2):190-6. doi: 10.1001/jamaneurol.2015.3886.

PMID:
26716735
9.

Clinical Perspective of Carotid Plaque Imaging.

Bonati LH, Nederkoorn PJ.

Neuroimaging Clin N Am. 2016 Feb;26(1):175-82. doi: 10.1016/j.nic.2015.09.012. Epub 2015 Oct 21. Review.

PMID:
26610668
10.

The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT.

Zonneveld TP, Algra A, Dippel DW, Kappelle LJ, van Oostenbrugge RJ, Roos YB, Wermer MJ, van der Worp HB, Nederkoorn PJ, Kruyt ND; TRUTH investigators.

BMC Neurol. 2015 Nov 23;15:241. doi: 10.1186/s12883-015-0493-z.

11.

Use of Antiplatelet Agents Is Associated With Intraplaque Hemorrhage on Carotid Magnetic Resonance Imaging: The Plaque at Risk Study.

Liem MI, Schreuder FH, van Dijk AC, de Rotte AA, Truijman MT, Daemen MJ, van der Steen AF, Hendrikse J, Nederveen AJ, van der Lugt A, Kooi ME, Nederkoorn PJ.

Stroke. 2015 Dec;46(12):3411-5. doi: 10.1161/STROKEAHA.115.008906. Epub 2015 Oct 29.

PMID:
26514191
12.

Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease.

van der Land V, Mutsaerts HJ, Engelen M, Heijboer H, Roest M, Hollestelle MJ, Kuijpers TW, Nederkoorn PJ, Cnossen MH, Majoie CB, Nederveen AJ, Fijnvandraat K.

Br J Haematol. 2016 Jan;172(2):274-84. doi: 10.1111/bjh.13819. Epub 2015 Oct 22.

PMID:
26492630
13.

Quality of life after surgical decompression for a space-occupying middle cerebral artery infarct: A cohort study.

van Middelaar T, Richard E, van der Worp HB, van den Munckhof P, Nieuwkerk PT, Visser MC, Stam J, Nederkoorn PJ.

BMC Neurol. 2015 Aug 28;15:156. doi: 10.1186/s12883-015-0407-0.

14.

Intraplaque Hemorrhage and the Plaque Surface in Carotid Atherosclerosis: The Plaque At RISK Study (PARISK).

van Dijk AC, Truijman MT, Hussain B, Zadi T, Saiedie G, de Rotte AA, Liem MI, van der Steen AF, Daemen MJ, Koudstaal PJ, Nederkoorn PJ, Hendrikse J, Kooi ME, van der Lugt A.

AJNR Am J Neuroradiol. 2015 Nov;36(11):2127-33. doi: 10.3174/ajnr.A4414. Epub 2015 Aug 6.

PMID:
26251429
15.

Diagnostic Accuracy of 4 Commercially Available Semiautomatic Packages for Carotid Artery Stenosis Measurement on CTA.

Borst J, Marquering HA, Kappelhof M, Zadi T, van Dijk AC, Nederkoorn PJ, van den Berg R, van der Lugt A, Majoie CB.

AJNR Am J Neuroradiol. 2015 Oct;36(10):1978-87. doi: 10.3174/ajnr.A4400. Epub 2015 Aug 6.

PMID:
26251425
16.

Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.

Seiffge DJ, Hooff RJ, Nolte CH, Béjot Y, Turc G, Ikenberg B, Berge E, Persike M, Dequatre-Ponchelle N, Strbian D, Pfeilschifter W, Zini A, Tveiten A, Næss H, Michel P, Sztajzel R, Luft A, Gensicke H, Traenka C, Hert L, Scheitz JF, De Marchis GM, Bonati LH, Peters N, Charidimou A, Werring DJ, Palm F, Reinhard M, Niesen WD, Nagao T, Pezzini A, Caso V, Nederkoorn PJ, Kägi G, von Hessling A, Padjen V, Cordonnier C, Erdur H, Lyrer PA, Brouns R, Steiner T, Tatlisumak T, Engelter ST; NOACISP Study Group*.

Circulation. 2015 Sep 29;132(13):1261-9. doi: 10.1161/CIRCULATIONAHA.115.015484. Epub 2015 Jul 31.

PMID:
26232277
17.

Outcomes are improving for patients with carotid stenosis.

Abbott AL, Nederkoorn PJ.

Neurology. 2015 Jul 28;85(4):302-3. doi: 10.1212/WNL.0000000000001793. Epub 2015 Jun 26. No abstract available.

PMID:
26115731
18.

Hospital costs of ischemic stroke and TIA in the Netherlands.

Buisman LR, Tan SS, Nederkoorn PJ, Koudstaal PJ, Redekop WK.

Neurology. 2015 Jun 2;84(22):2208-15. doi: 10.1212/WNL.0000000000001635. Epub 2015 May 1.

19.

Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.

Compter A, van der Worp HB, Schonewille WJ, Vos JA, Boiten J, Nederkoorn PJ, Uyttenboogaart M, Lo RT, Algra A, Kappelle LJ; VAST investigators.

Lancet Neurol. 2015 Jun;14(6):606-14. doi: 10.1016/S1474-4422(15)00017-4. Epub 2015 Apr 20.

PMID:
25908089
20.

Unexplained early-onset lacunar stroke and inflammatory skin lesions: Consider ADA2 deficiency.

Westendorp WF, Nederkoorn PJ, Aksentijevich I, Hak AE, Lichtenbelt KD, Braun KP.

Neurology. 2015 May 19;84(20):2092-3. doi: 10.1212/WNL.0000000000001581. Epub 2015 Apr 17. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk